Stevanato Group S.p.A $STVN

Health Care

$19.50
+0.68 (+3.61%)
As of Oct 22, 2026, 9:33 PM EDT · cached
Price history
Loading chart…

Stevanato Group S.p.A (STVN) is trading up at $19.50 (+3.61%), as of the latest quote. It operates in the Health Care sector.

IPO: July 16, 2021 · $21.00 offering · NYSE · View IPO details →

Stevanato Group S.p.A revenue & net income history (FY2019–FY2025)

RevenueNet incomeNet margin (right axis, %)
€1.19B€593.1M€0FY2019 revenue: €536.5MFY2019 net income: €39.2M · Net margin 7.3%'19FY2020 revenue: €662.0MFY2020 net income: €78.5M · Net margin 11.9%'20FY2021 revenue: €843.9MFY2021 net income: €134.3M · Net margin 15.9%'21FY2022 revenue: €983.7MFY2022 net income: €142.8M · Net margin 14.5%'22FY2023 revenue: €1.09BFY2023 net income: €145.6M · Net margin 13.4%'23FY2024 revenue: €1.10BFY2024 net income: €117.8M · Net margin 10.7%'24FY2025 revenue: €1.19BFY2025 net income: €139.8M · Net margin 11.8%'250%5%10%15%20%FY2019 net margin: 7.3%FY2020 net margin: 11.9%FY2021 net margin: 15.9%FY2022 net margin: 14.5%FY2023 net margin: 13.4%FY2024 net margin: 10.7%FY2025 net margin: 11.8%
Stevanato Group S.p.A annual financial statements
FY2019Dec 2019FY2020Dec 2020FY2021Dec 2021FY2022Dec 2022FY2023Dec 2023FY2024Dec 2024FY2025Dec 2025
Income statement
Revenue€536.5M€662.0M€843.9M€983.7M€1.09B€1.10B€1.19B
Growth (year over year)—+23.4%+27.5%+16.6%+10.3%+1.7%+7.4%
Gross profit€138.0M€194.2M€265.4M€319.8M€339.9M€302.3M€343.9M
Gross margin25.7%29.3%31.4%32.5%31.3%27.4%29.0%
Operating income€62.2M€103.1M€162.2M€192.4M€200.7M€161.1M€198.8M
Operating margin11.6%15.6%19.2%19.6%18.5%14.6%16.8%
Net income€39.2M€78.5M€134.3M€142.8M€145.6M€117.8M€139.8M
Net margin7.3%11.9%15.9%14.5%13.4%10.7%11.8%
EPS (diluted)€0.16€0.33€0.53€0.54€0.55€0.43€0.51
Balance sheet
Cash and equivalents€85.4M€115.6M€411.0M€228.7M€69.6M€98.3M€130.6M
Total assets—€968.0M€1.42B€1.66B€2.07B€2.33B€2.54B
Total liabilities—€657.8M€577.2M€663.8M€938.9M€924.4M€1.06B
Shareholders' equity€265.4M€310.5M€842.1M€996.1M€1.13B€1.40B€1.49B
Cash flow
Operating cash flow€42.6M€155.7M€133.3M€103.3M€105.2M€155.8M€286.1M
Capital expenditure€68.1M€89.6M€107.7M€235.0M€433.2M€302.6M€263.8M
Free cash flow−€25.5M€66.1M€25.6M−€131.7M−€328.0M−€146.8M€22.3M
Dividends paid€6.17M€8.90M€11.2M€13.5M€14.3M€14.5M€14.7M

From Stevanato Group S.p.A's 20-F filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. Amounts are in Euro (EUR), as reported, not converted to dollars. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →

About Stevanato Group S.p.A

Headquarters
Padua, Italy From SEC filings, Oct 2026

Recent News

No recent news mentioning Stevanato Group S.p.A in our feed yet.

More Health Care stocks

Browse all companies →